3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
4
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Gynecologic
1
Conditions
Lymphoma, Large B-Cell, Diffuse
4
Breast Neoplasms
4
Burkitt Lymphoma
3
Uterine Cervical Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Ovarian Neoplasms
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Mantle-Cell
2
Lymphoma, Large-Cell, Immunoblastic
2
Lymphoma, Follicular
2
Lymphoma, B-Cell, Marginal Zone
2
Lymphoma
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Colonic Neoplasms
2
Carcinoma, Ovarian Epithelial
2
Wilms Tumor
1
Waldenstrom Macroglobulinemia
1
Uterine Cervical Dysplasia
1
Urinary Bladder Neoplasms
1
Testicular Neoplasms
1
Testicular Germ Cell Tumor
1
Teratoma
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Spinal Cord Neoplasms
1
Sezary Syndrome
1
Sarcoma
1
Salivary Gland Neoplasms
1
Rhabdoid Tumor
1
Recurrence
1
Interventions
tremelimumab
1
peginterferon alfa-2b
1
Zoledronic Acid
1
Zidovudine
1
Whole-Body Irradiation
1
Valproic Acid
1
Tetradecanoylphorbol Acetate
1
Sodium Chloride
1
Selenium
1
Rosuvastatin Calcium
1
Rituximab
1
Ribavirin
1
Peripheral Blood Stem Cell Transplantation
1
Oxycodone
1
Observation
1
Moxifloxacin
1
Morphine
1
Microarray Analysis
1
Methadone
1
Laser Therapy
1
Interferon alpha-2
1
Infliximab
1
Gene Expression Profiling
1
Gadolinium DTPA
1
Fluorodeoxyglucose F18
1
Flow Cytometry
1
Fentanyl
1
Colposcopy
1
Ciprofloxacin
1
Chromatography, High Pressure Liquid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Precancerous Conditions
×
Microarray Analysis
×
Clear all
NCT00629577
2017-02-01
SAGE
British Columbia Cancer Agency
Phase 1
Terminated
50 enrolled